PharmiWeb.com - Global Pharma News & Resources
02-Apr-2019

aap Implantate AG: Sales in Q1/2019 with EUR 3.5 million by EUR 0.5 million above the guidance

aap Implantate AG / Key word(s): Preliminary Results/Development of Sales
aap Implantate AG: Sales in Q1/2019 with EUR 3.5 million by EUR 0.5 million above the guidance


Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.



02-Apr-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: aap Implantate AG
Lorenzweg 5
12099 Berlin
Germany
Phone: +49 (0) 30 75 01 90
Fax: +49 (0) 30 75 01 91 11
E-mail: info@aap.de
Internet: www.aap.de
ISIN: DE0005066609
WKN: 506660
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 794637

 
End of Announcement DGAP News Service

Editor Details

Last Updated: 02-Apr-2019